跳至主要内容
临床试验/NCT02208596
NCT02208596Unknown4 期

The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial

Third Affiliated Hospital of Zhengzhou University0 个研究点目标入组 150 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
150
主要终点
Heart rate

研究概览

简要总结

To explore the feasibility of different doses of etomidate admixed with propofol in induced abortion: a randomized, double blind controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 20 and 35 years
  • American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ
  • Singleton pregnancy and the gestational period is 6 to 8 weeks
  • Expected operation duration is within 60 minutes
  • The body weight should be within 15% around the standard weight
  • Signed informed consent form

排除标准

  • Serious cardiac, cerebral, liver, kidney, lung, endocrine disease
  • Upper respiratory infections within 4 weeks
  • Long use of hormone or history of adrenal suppression
  • History of use of glucocorticoids, aprotinin or immunosuppressant
  • Manifestation of immunodeficiency
  • History of use of sedatives or opiates
  • Needs of Neuromuscular blocker (except intubation)
  • Allergy to trial drug or other contraindication
  • Pregnant or breast-feeding women
  • Attended other trial past 30 days

研究组 & 干预措施

Group A

Experimental

In group A, propofol (1%) was mixed with etomidate in the ration of 1:1 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: pentazocine (Drug)

Group A

Experimental

In group A, propofol (1%) was mixed with etomidate in the ration of 1:1 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: propofol (Drug)

Group A

Experimental

In group A, propofol (1%) was mixed with etomidate in the ration of 1:1 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: Etomidate (Drug)

Group B

Experimental

In group B, propofol (1%) was mixed with etomidate in the ration of 7:5 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: pentazocine (Drug)

Group B

Experimental

In group B, propofol (1%) was mixed with etomidate in the ration of 7:5 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: propofol (Drug)

Group B

Experimental

In group B, propofol (1%) was mixed with etomidate in the ration of 7:5 (volume). The mixture will be injected continuously until the eyelash reflex disappears. During the operation, supplementary mixture will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: Etomidate (Drug)

Group C

Experimental

In group C, propofol (1%) will be injected continuously until the eyelash reflex disappears. During the operation, supplementary propofol will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: pentazocine (Drug)

Group C

Experimental

In group C, propofol (1%) will be injected continuously until the eyelash reflex disappears. During the operation, supplementary propofol will be administered if the patient has spontaneous movement that hampered the conduct of the procedure.

干预措施: propofol (Drug)

结局指标

主要结局

Heart rate

时间窗: From baseline (before the injection of propofol or mixture of propofol and etomidate) to 10 min after the injection

Heart rate will be recorded immediately when the patient arrived at the operating room, 2 min, 4 min, 6 min, 8 min and 10 minutes after the the injection of propofol or mixture of propofol and etomidate.

Blood pressure

时间窗: From baseline (before the injection of propofol or mixture of propofol and etomidate) to 10 min after the injection

Blood pressure will be recorded immediately when the patient arrived at the operating room, 2 min, 4 min, 6 min, 8 min and 10 minutes after the the injection of propofol or mixture of propofol and etomidate.

Pulse oxygen saturation

时间窗: From baseline (before the injection of propofol or mixture of propofol and etomidate) to 10 min after the injection

Pulse oxygen saturation will be recorded immediately when the patient arrived at the operating room, 2 min, 4 min, 6 min, 8 min and 10 minutes after the the injection of propofol or mixture of propofol and etomidate.

次要结局

  • Dose of propofol or mixture of propofol and etomidate(from the injection of propofol or mixture of propofol and etomidate to the last supplement of hypnotic agents, expected to be no more than 5 min)
  • Use of specific medications(from the injection of propofol or mixture of propofol and etomidte to discharge from the hospital, expected to no more than 1 hour)
  • Aldrete score(10 min after the opration)
  • Satisfaction degree of the patient, the surgeon and the anesthetist(10 min before discharge from the hospital)
  • Efficacy of anesthesia(from baseline to discharge from the hospital, expected to no more than 1 hour)
  • Verbal rating scales of uterine contraction(from 5 min after the operation to discharge from the hospital, expected to be no more than 1 hour)

研究者

发起方
Third Affiliated Hospital of Zhengzhou University
申办方类型
Other
责任方
Sponsor

相似试验

The Feasibility of Different Doses of Etomidate... | 临床试验